Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705327 · ClinicalTrials.gov registry record
Fox Investigation for New Discovery of Biomarkers
A clinical trial, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- Completed
- Registry status
- 240
- Enrollment target
NCT01705327 is a clinical trial that has completed, run by Michael J. Fox Foundation for Parkinson's Research. The registered enrollment target is 240 participants.
The verdict
NCT01705327 has completed, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This is an observational, multi-center study to assess clinical features and biologic biomarkers in Parkinson's disease (PD) patients compared to healthy controls (HC). The primary objective of this study is to discover clinical and biologic markers of PD for use in clinical trials of disease-modifying therapies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01705327
The ClinicalTrials.gov registry entry for NCT01705327 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael J. Fox Foundation for Parkinson's Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01705327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01705327 about?
NCT01705327 is a clinical study titled "Fox Investigation for New Discovery of Biomarkers". This is an observational, multi-center study to assess clinical features and biologic biomarkers in Parkinson's disease (PD) patients compared to healthy controls (HC). The primary objective of this study is to discover clinical and biologic markers of PD for use in clinical trials of disease-modify...
What is the current status of trial NCT01705327?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2012-10. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT01705327?
This trial is sponsored by Michael J. Fox Foundation for Parkinson's Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.